Quantification of neomycin in rubella vaccine by off/on metal ion mediated photoluminescence from functionalized graphene quantum dots
-
Add time:08/29/2019 Source:sciencedirect.com
The determination of neomycin sulfate was made using photoluminescent amino-functionalized graphene quantum dots (obtained from hydro-exfoliation of a mixture of citric acid and glutathione). From the several ions tested, Fe3+ was the best mediator to enable an off/on photoluminescence effect used for quantification. The mediation of Fe3+ was found to be crucial as it is responsible for the photoluminescence quenching effect, due to the interaction with quantum dots surface, also having large affinity towards neomycin that removes Fe3+ from the surface of GQDs, consequently, promoting restoration of the original nanomaterial photoluminescence. Such signal restoration was proportional to the neomycin sulfate concentration added. The linearized analytical response covered three orders of magnitude (10−7 to 10−5 mol L−1). The proposed method is an alternative to those requiring labor-intensive procedures for chemical the derivatization of neomycin (due to the lack of chromophore groups in aminoglycosides). The method was successfully tested in the analysis of rubella vaccine containing trace residues of neomycin and in pharmaceutical compositions containing neomycin sulfate after solid phase extraction using an aminoglycoside imprinted polymer to improve selectivity in determinations.
We also recommend Trading Suppliers and Manufacturers of NEOMYCIN B (cas 119-04-0). Pls Click Website Link as below: cas 119-04-0 suppliers
Prev:Neomycin-dependent hammerhead ribozymes for the direct control of gene expression in Saccharomyces cerevisiae
Next:Synthesis and antibacterial activity of amphiphilic lysine-ligated NEOMYCIN B (cas 119-04-0) conjugates) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Identification of NEOMYCIN B (cas 119-04-0)-binding site in T box antiterminator model RNA09/04/2019
- Efficient synthesis of NEOMYCIN B (cas 119-04-0) related aminoglycosides09/03/2019
- Integrated nanotechnology of synergism-sterilization and removing-residues for neomycin through nano-Cu2O09/02/2019
- SPR sensing of small molecules with modified RNA aptamers: Detection of NEOMYCIN B (cas 119-04-0)09/01/2019
- Paromomycin and NEOMYCIN B (cas 119-04-0) derived cationic lipids: Synthesis and transfection studies08/31/2019
- Synthesis and antibacterial activity of amphiphilic lysine-ligated NEOMYCIN B (cas 119-04-0) conjugates08/30/2019
- Neomycin-dependent hammerhead ribozymes for the direct control of gene expression in Saccharomyces cerevisiae08/28/2019
- Original articlePRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitisÉtude PRISM : comparaison de l’association nystatine-néomycine-polymyxine B versus miconazole dans le traitement probabiliste de la vaginite infectieuse☆08/27/2019
- NEOMYCIN B (cas 119-04-0)-cyclen conjugates and their Zn(II) complexes as RNA-binding agents☆08/26/2019
-
Health and Chemical more >